PointState Capital LP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q4 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
PointState Capital LP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2019$930,000
+44.2%
10,600
+158.5%
0.02%
+30.8%
Q1 2019$645,000
-95.8%
4,100
-97.6%
0.01%
-91.9%
Q1 2017$15,304,000
+122.5%
168,362
+124.5%
0.16%
+36.8%
Q4 2014$6,879,000
+47.5%
75,000
-42.3%
0.12%
+37.6%
Q3 2014$4,664,000
-56.0%
130,000
-52.7%
0.08%
-36.1%
Q2 2014$10,607,000
+405.6%
275,000
+175.0%
0.13%
+392.6%
Q4 2013$2,098,000
-61.1%
100,000
-50.0%
0.03%
-70.7%
Q3 2013$5,392,000200,0000.09%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 82,500$5,090,0004.20%
RTW INVESTMENTS, LP 122,576$7,563,0002.85%
Eventide Asset Management 587,677$36,260,0002.36%
First Light Asset Management, LLC 71,246$4,396,0001.93%
ARK Investment Management 75,645$4,667,0001.70%
Taylor Wealth Management Partners 39,118$2,414,0001.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 302,027$18,635,0000.77%
ARMISTICE CAPITAL, LLC 40,000$2,468,0000.58%
Artal Group S.A. 422,536$26,070,0000.58%
Baillie Gifford 5,164,467$318,647,0000.52%
View complete list of BLUEBIRD BIO INC shareholders